Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke

The article titled “Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke”, by Rucheng Liu et al., published in Current Stem Cell Research & Therapy 2022; 17. 10.2174/1574888X16666210812151003 has been withdrawn upon the request of the authors. The authors found that invalid references were cited. Consequently, the authors concluded that the results could not be guaranteed.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

Bentham Editorial Policy on Article Withdrawn can be found at https://benthamscience.com/editorial-policies-main.php.

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.